acetaminophen 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet

RxCUI
1242618
RxNorm name
acetaminophen 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet
Display name
Acetaminophen/Doxylamine/Salicylamide (Oral Pill)
Full name
acetaminophen 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet
Term type
SCD
Status
Active
Strength
250-25-150 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-17 23:46:16

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022012
Active start
022012
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
acetaminophen250 MG / 1 EACHacetaminophenacetaminophen
doxylamine succinate25 MG / 1 EACHdoxylaminedoxylamine succinate
salicylamide150 MG / 1 EACHsalicylamidesalicylamide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
acetaminophen161
doxylamine3642
salicylamide9518

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00731013501rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AAAminoalkyl ethersATC1-4doxylamine
ATCN02BEAnilidesATC1-4acetaminophen
ATCN02BASalicylic acid and derivativesATC1-4salicylamide
FDASPLN0000175750AntihistamineEPChas_epcdoxylamine
FDASPLN0000000207Histamine Receptor AntagonistsMOAhas_moadoxylamine
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD004319DoxylamineCHEMhas_ingredientdoxylamine
MEDRTD004319DoxylamineCHEMhas_ingredientdoxylamine succinate
MEDRTD012457SalicylamidesCHEMhas_ingredientsalicylamide
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylamide
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxylamine
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxylamine succinate
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005334FeverDISEASEmay_treatsalicylamide
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD006261HeadacheDISEASEmay_treatdoxylamine succinate
MEDRTD006261HeadacheDISEASEmay_treatdoxylamine
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD010146PainDISEASEmay_treatsalicylamide
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdoxylamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdoxylamine succinate
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdoxylamine
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdoxylamine succinate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moasalicylamide
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadoxylamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadoxylamine succinate
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008657Decreased Histamine ActivityPEhas_pedoxylamine succinate
MEDRTN0000008657Decreased Histamine ActivityPEhas_pedoxylamine
MEDRTN0000008832Decreased Platelet AggregationPEhas_pesalicylamide
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pesalicylamide
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH250 MG / 25 MG (expressed as doxylamine succinate) / 150 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymacetaminophen 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet
SOURCESSourceMicromedex RED BOOK